key: cord-0828539-tybf8fep
authors: D'Amico, Filippo; Marmiere, Marilena; Righetti, Beatrice; Scquizzato, Tommaso; Zangrillo, Alberto; Puglisi, Riccardo; Landoni, Giovanni
title: COVID-19 seasonality in temperate countries
date: 2022-04-15
journal: Environ Res
DOI: 10.1016/j.envres.2021.112614
sha: 3e8c3a4695ade6f8d9ac3ebf040e0e0fd0a2d34a
doc_id: 828539
cord_uid: tybf8fep

INTRODUCTION: While the beneficial effect of vaccination, restrictive measures, and social distancing in reducing mortality due to SARS-CoV-2 is intuitive and taken for granted, seasonality (predictable fluctuation or pattern that recurs or repeats over a one-year period) is still poorly understood and insufficiently taken into consideration. We aimed to examine SARS-CoV-2 seasonality in countries with temperate climate. METHODS: We identified countries with temperate climate and extracted average country temperature data from the National Center for Environmental information and from the Climate Change Knowledge Portal. We obtained mortality and vaccination rates from an open access database. We used the stringency index derived from the Oxford COVID-19 Government Response Tracker to quantify restriction policies. We used Spearman's and rank-correlation non-parametric test coefficients to investigate the association between COVID-19 mortality and temperature values. We employed multivariate regression models to analyze how containment measures, vaccinations, and monthly temperatures affected COVID-19 mortality rates. RESULTS: The time series for daily deaths per million inhabitants and average monthly temperatures of European countries and US states with a temperate climate had a negative correlation (p < 0.0001 for all countries, 0.40 < R < 0.86). When running multivariate regression models with country fixed effects, we noted that mortality rates were significantly lower when temperature were higher. Interestingly, when adding an interaction term between monthly temperatures and vaccination rates, we found that as monthly temperatures dropped, the effect of the vaccination campaign on mortality was larger than at higher temperatures. DISCUSSION: Deaths attributed to SARS-CoV-2 decreased during the summer period in temperate countries. We found that the effect of vaccination rates on mortality was stronger when temperatures were lower. Stakeholders should consider seasonality in managing SARS-CoV-2 and future pandemics to minimize mortality, limit the pressure on hospitals and intensive care units while maintaining economic and social activities.

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first broke out in Wuhan, China. The World Health Organization declared COVID-19 a global pandemic on March 11 th , 2020 [1] . Over this two-year period, healthcare systems worldwide faced an unprecedented challenge [2] .

In anticipation of a widely accessible vaccine or an effective cure for COVID-19, governments implemented non-pharmaceutical measures, notably self-isolation and lockdown, to limit virus spreading and the overall pandemic impact on national healthcare systems. Results suggest that lockdowns were effective in reducing cases and in containing the pandemic [3] . The vaccination campaign is rapidly advancing, especially in developed countries, and is associated with a clear reduction in the number of SARS-CoV-2 infections, attenuation of viral RNA load, symptoms, and illness duration among those with breakthrough infection despite vaccination. [4] .

However, the pandemic dynamics, even if attenuated by health policies, is still to be comprehensively understood. The seasonal cycle of several respiratory viruses is well-known and studied [5] . For example, the influenza virus affects the human population during the winter season in temperate regions [6] . Coronaviruses exhibit winter seasonality but, as far as SARS-CoV-2 is concerned, there is no clear consensus supporting this assumption [7] . Several factors interfered with the SARS-CoV-2 pandemic course, making it difficult to disentangle the role played by human interventions with respect to its evolution, and thus to estimate the effectiveness of these measures. Understanding whether or not SARS-CoV-2 has seasonal features is essential for directing future health policies and identifying the current state of the pandemic. Countries with extreme or non-temperate climates, such as the majority of the United States of America (US) or Equatorial countries (e.g., Brazil and Indonesia), may not J o u r n a l P r e -p r o o f 6 have a sufficient degree of climate variability to display seasonality. In countries with a temperate climate, such as those of the Mediterranean area, the course of the pandemic during the summer months seems to have a concordant mortality rate timeline, regardless of the containment measures adopted and the extent of the vaccination campaign.

The aim of this work is to study whether countries with a temperate climate -such as those of the Mediterranean area -display significant seasonality (i.e., an inverse correlation between temperature and COVID-19 mortality), as well as to correlate the concurrent time series variation in the stringency of containment measures and in the level of the vaccination campaign.

We considered the pandemic period from April 1 st , 2020, to July 1 st , 2021, and limited our analyses to the Northern Hemisphere countries (or states in case of the US). Following the Köppen climate classification [8] , we selected and studied temperate climate countries only defined as countries whose mean temperature is above −3 °C (26.6 °F) and below 18 °C (64.4 °F) in the coldest month. Overall, only 10 European countries (Albania, Belgium, France, Greece, Italy, Netherlands, North Macedonia, Portugal, Spain, United Kingdom), and 6 US states (Alabama, Arkansas, Georgia, Mississippi, South Carolina, Tennessee), fulfilled the inclusion criteria. We excluded states with less than 100 total deaths (New Zeland, San Marino, Vatican) and those in the Southern Hemisphere (Uruguay, New Zeland). No other countries in Asia, Africa, and North and South America were included since they have a temperate climate only in partial areas of their extension and therefore cannot be considered temperate countries [9] . We obtained temperature data for European countries from the World Bank's Climate Change Knowledge Portal [10] , and for states in the US from NOAA's National Center for Environmental information [11] . We extracted mortality and vaccination rates from the public J o u r n a l P r e -p r o o f database managed by Johns Hopkins University [12] . This study did not require ethics committee approval because data were already in the public domain.

We quantified restriction policies by means of the stringency index from the Oxford COVID-19 Government Response Tracker (OxCGRT). This is a composite measure based on nine response indicators including school closure, workplace closure and travel bans, recorded on a scale from 0 to 100, the latter being the most stringent measure. [13] We compared restriction policies concordance over time among countries. In addition, we compared stringency index time series with daily mortality rate. We then correlated the mortality trends with vaccination rates.

Through a descriptive analysis we provided an overview of COVID-19 mortality and climate temperature during the study period, and we then correlated temperature with daily mortality rate. We also conducted a time series analysis for daily mortality rate and temperature to evaluate concordance. Data were downloaded from the above described publicly available databases, plotted using Microsoft Excel (Microsoft Corporation, 2018) and graphically represented. For time series of data, we used a linear regression model to fit the dependent variable COVID-19 mortality with the monthly average meteorological parameter (air temperature expressed in degree Celsius, C°) and daily stringency index. The dependence between pairs of time series was quantified in this study by standard tools of statistical analysis, Spearman's and rank-correlation nonparametric test coefficients. The normality of data was evaluated using Kolmogorov-Smirnov Tests for Normality for time series data sets. As the data on daily new COVID-19 deaths showed non-normal distribution, Spearman's rank correlation was selected to investigate the association between COVID-19 mortality and temperature data, using STATA 16 software.

The Bonferroni correction was applied for multiple comparison. We used non-parametric J o u r n a l P r e -p r o o f statistical tests since they are more suitable than parametric tests for non-normally distributed data, such as the climate variable we employed in our study. The values for levels of correlation are bound in the range [0, +1], with 0 for no association and +1 for complete positive association and [0, -1] with -1 as negative correlation. P values <0.05 were considered statistically significant.

We then run a set of multivariate linear regressions in order to check whether the bivariate correlations between (i) COVID-19 mortality and temperatures, (ii) COVID-19 mortality and vaccinations and (iii) COVID-19 mortality and containment measures were robust, to jointly analyze them and to control for other confounding factors. In fact, throughout the multivariate analysis we included country/state fixed effects (i.e., we controlled for time-invariant features of each location that might be correlated with our explanatory variables of interest). Standard errors were robust to heteroscedasticity. We considered again the period from April 2020 to June 2021, and we introduced a 20-days delay when analyzing the correlation between stringency index, number of SARS-CoV-2 positive cases and COVID-19 mortality, and therefore analyses started on April 21 st , 2020. We added an interaction term between average monthly temperature and the percentage of fully vaccinated people, per hundred: the purpose of this addition was to investigate whether vaccination rates were differentially effective on COVID-19 mortality as a function of average temperatures. We also added an interaction term between the 20-days lagged number of new COVID-19 cases and the percentage of fully vaccinated people, to check whether the vaccination effort dampened the relationship between new COVID-19 cases and mortality.

We identified 16 countries (10 countries in Europe and 6 states in the US) located in the Northern Hemisphere with a temperate climate and with more than 100 COVID-19 deaths in the studied period (April 1 st , 2020 to July 1 st , 2021).

Average monthly temperatures (supplemental Table 1 When analyzing US temperate states, we found similar seasonal trends (supplemental Table 1 , supplemental Figure 7 ) which were more considerable starting from winter 2020. We confirmed the negative correlation between temperature and mortality through multivariate regression analyses including all the sixteen countries involved in the study (supplemental Table 2 ). In particular, an increment of one degree Celsius above the average temperature was associated with a reduction of about 61 COVID-19 deaths per million on a yearly basis (supplemental Table 2 ).

We also confirmed the negative correlation between vaccination rate and COVID-19 daily death per million: again, on a yearly basis, one percent increase of fully vaccinated individuals was associated with a reduction of about 27 COVID-19 deaths per million (supplemental Table   2 ). Table 2 ). The Table 2 ). Finally, the negative correlation between the stringency index and COVID-19 mortality was confirmed only by the more parsimonious specification of the multivariate analysis that did not control for the number of new COVID-19 cases (supplemental Table 2 ).

The most remarkable result of our study is to document that COVID-19-attributed deaths are closely related to temperature variations in temperate countries: as temperatures increase in late spring, the number of COVID-19 deaths dramatically decreases. These findings were more statistically robust in the case of European countries than in the case of US states. We also found that the decrease in mortality observed in late spring 2021 was not only related to the progression of the vaccination campaign in these countries, but also to the therein climatic conditions. We demonstrated that each percentage point of vaccinated people corresponds to a reduction of 27 COVID-19 yearly deaths per million. The summer decrease in COVID-19 mortality was concordant in all countries, regardless of the different vaccination rates. Macedonia and Albania, whose rate of people that received complete vaccination did not exceed 20%, presented a summer decrease in mortality similar to that of the other temperate J o u r n a l P r e -p r o o f climate countries. Moreover, we demonstrated that vaccinations have larger impact on mortality at low temperatures, while at higher temperatures their impact on mortality decreased. This suggests that temperatures were pivotal for the striking mortality drop during the summer months.

Our work can be compared to other previously published studies on seasonality and COVID-19, among which are also some focused on non-temperate areas that failed to show an association with temperature changes [14] [15] [16] . Bukhari et al. demonstrated that 90% of SARS-CoV-2 infections during the early months of the pandemic occurred at relatively cold temperatures, between 5 and 10 degrees Celsius [17] . Other studies confirmed the seasonal trend of COVID-19 mortality, but none of them focused on temperate climate countries only.

Some of them analyzed individual countries or cities [18] [19] [20] [21] , while others arbitrarily selected sets of states around the world with significant climate differences [22, 23] . In addition, most papers focused on incidence rates, which may be biased by the testing capacity of individual countries [18] [19] [20] [21] [22] [23] [24] [25] .

Respiratory viral infections generally show seasonality [6] , as revealed by previous pandemics that showed significant correlations with climate conditions. Conventionally, the surveillance period for seasonal influenza runs from the 42 nd week of the year until the 17 th week of the following one [26] . This climate-related seasonality happens in both hemispheres [27] . In Our findings have clinical, epidemiological, and social impact. First, policy makers should beware of the influence of climate temperature on the pandemics when estimating the effectiveness and planning of restrictive measures. When acknowledging this interference, we might assume that early autumn increase in mortality is not to be related to human behavior during the summer season but represents the normal progression of a seasonal pandemic trend, and that the decrease in mortality during late spring is not only an effect of restrictions.

Secondly, since restrictive measures are intuitively effective in reducing cases and containing pandemic mortality, it would be possible to reinforce or ease them weeks or months in advance.

As we are able to predict the progression of the curve, it is feasible to form longer-term plans, Further studies could be conducted to understand how climate affects the virus. By graphically evaluating mortality time series in temperate countries, we observed a decrease in January, the month when temperatures are the lowest. It would be important to understand whether the relationship between environmental temperatures and mortality is linear or SARS-CoV-2 manifests its effects in an optimal range of temperatures. Furthermore, the reasons behind this phenomenon are unknown and have been topic of scientific discussion for centuries. The main suggested explanations are the following: (i) the different human behaviors during the cold and hot seasons that expose differently to virus transmission (i.e., closed working environments with less air circulation, opening schools and work); (ii) the different human response to virus for endocrine-immunological factors or physical barriers (i.e., Vitamin D, adaptive immunity to viruses, mucosal integrity, mucus production); or (iii) even the instability of the virus (i.e., UV exposure, direct effect of temperature) [25] . Moreover, possible therapeutic implications and the applicability to other viruses -to prevent a possible future pandemic -have never been studied so far.

While the mortality rates can be influenced by testing capacity, classification of COVID-19related deaths, health system capacity, nutritional habits, pollution, and population density, the trend of mortality over time, especially if concordant across countries, is an objective parameter. Nonetheless, we acknowledge some limitations. First, the epidemic has been ongoing for only two years, so the analysis is limited in time. Second, we do not know whether our findings apply to countries with non-temperate climates. Third, we did not analyze the delay between temperature changes and variations in mortality. Fourth, we were not able to consider the effect of change in medical treatments for COVID-19 that improved outcome and decreased mortality over time [37] which, however, implausibly influenced the same summer mortality reduction in two different pandemic years that we found. Lastly, we do not know if or the viral load, affecting disease severity.

We showed COVID-19 pandemic seasonality in temperate countries. Policy makers of temperate countries should consider SARS-CoV-2 seasonality when deciding the timing of vaccine booster doses and of restrictive measures, with the purpose of better preventing the progression of the pandemic.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

WHO Director-General's opening remarks at the media briefing on COVID-19-11

Coronavirus disease (COVID-19): weekly epidemiological update

Lancet Infect Dis. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Influenza seasonality: underlying causes and modeling theories

Annu Rev Virol. Seasonality of Respiratory Viral Infections

Lancet Infect Dis. Seasonality of infectious diseases and severe acute respiratory syndrome-what we don't know can hurt us

Das geographische System der Klimate (Handbuch der Klimatologie, Bd. 1, Teil C)

Sci Data. Present and future Köppen-Geiger climate classification maps at 1-km resolution

Climate change knowledge portal for development practitioners and policy makers

Climate at a Glance: Global Time Series

Lancet Infect Dis. An interactive web-based dashboard to track COVID-19 in real time

Nat Hum Behav. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)

Effect of meteorological parameters on spread of COVID-19

in India and air quality during lockdown

Environ Res. Meteorological conditions are heterogeneous factors for COVID-19 risk in China

Is coronavirus disease (COVID-19) seasonal? A critical analysis of empirical and epidemiological studies at global and local scales

Will coronavirus pandemic diminish by summer?

Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid

One Health. Comparable seasonal pattern for COVID-19 and flu-like illnesses

On the Environmental Determinants of COVID-19 Seasonality

A spatial model of COVID-19 transmission in England and Wales: early spread, peak timing and the impact of seasonality

Proc Natl Acad Sci U S A. Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions

COVID-19: relationship between atmospheric temperature and daily new cases growth rate

Can Commun Dis Rep. Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19

Sci Rep. Ambient temperature and subsequent COVID-19 mortality in the OECD countries and individual United States

World Health Organization 27. Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season WHO report 2006-02-14

Epidemic Influenza. A Survey

Influenza: the mother of all pandemics

Pandemic (H1N1) 2009 -update 100". Disease Outbreak News. World Health Organization(WHO)

Pandemic influenza in 1957: Review of international spread of new Asian strain

Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics

Epidemiology of the Hong Kong-68 variant of influenza A2 in Britain

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1

SARS: what have we learned

Decreased in-hospital mortality in patients with COVID-19 pneumonia